AstraZeneca sales fall further as generic competition bites deep
April 27, 2017 at 02:14 AM EDT
LONDON, April 27 (Reuters) - AstraZeneca, struggling with loss of patents on blockbusters like cholesterol pill Crestor, reported another quarter of falling drug sales on Thursday as it awaits pivotal clinical trial data that may revive its fortunes.